多発性硬化症の遺伝的リスク変異のアレル調節活性に関する全ゲノムの発見
Marissa Granitto1,2,3, Lois Parks1,3,4, Molly S Shook1,3
1Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
G3 (Bethesda, Md.)
|August 21, 2025
まとめ
この研究は,多発性硬化症 (MS) リスクロシウムの遺伝子発現を制御する遺伝的変異を特定します. これらの発見は この複雑な神経疾患に寄与する 遺伝子制御メカニズムを明らかにしています
科学分野:
- 神経免疫学
- 遺伝学
- 分子生物学
背景:
- 多発性硬化症 (MS) は,中枢神経系 (CNS) の免疫媒介による脱ミエリン性疾患である.
- 遺伝的要因が多発性硬化症の病因に寄与し,多くのリスク変異は非コーディング領域に存在する.
- 遺伝子変異が遺伝子発現にどう影響するかを理解することは,MSの病原性を解明するために極めて重要です.
研究 の 目的:
- MSリスクロシオ内の遺伝子型に依存する規制活動を持つ遺伝的リスク変異を特定する.
- MSに関連する遺伝子発現の変化におけるこれらの変異体の役割を調査する.
- MSの根底にある遺伝的メカニズムを理解するためのリソースを提供すること.
主な方法:
- マッシヴ・パラレル・レポーター・アッセイ (MPRA) を使って 14,275 のMSの遺伝的リスク変異を検査した.
- MS患者のEBV変異B細胞系とGM12878細胞系にMPRAライブラリを適用した.
- 遺伝子型に依存した変異の強化と静止作用を分析した.
主要な成果:
- 150のアルレル強化変異体と286のアルレル静止変異体が見つかりました
- これらの変異は83の独立したMSリスクロキーを表しています.
- 既知のMSリスクロシウムの3分の1以上において,潜在的に因果的な遺伝子型依存の遺伝子調節メカニズムを特定した.
結論:
- この研究は,MSリスクローシ内の遺伝子発現を制御する特定の遺伝的変異を示唆しています.
- これらの発見は,MSの病原性の遺伝的基盤についての洞察を提供します.
- MSの遺伝的メカニズムに関する 将来の研究に貴重な情報源となります
さらに関連する動画
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.1K
10:17An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
Published on: November 3, 2010
23.0K
関連する概念動画
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Comparing Copy Number Variations and SNPs
17.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
Single Nucleotide Polymorphisms-SNPs
15.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.9K
Human Genetics
719
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
719
